From professional translators, enterprises, web pages and freely available translation repositories.
la perfusion de biliburine n'eut pas effet sur la fonction rénale.
the infusion of bilirubin was without effect on renal function.
Last Update: 2015-05-14
Usage Frequency: 1
Quality:
· augmentation de biliburine dans votre sang, pouvant entraîner une coloration jaunâtre de la
· increased amounts of bilirubin in your blood, which may cause yellowing of the skin and may
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
l'hypothèse que la biliburine et la biliverdine non conjuguées soient des antioxydants cytoprotecteurs fut d'abord examinée dans des systèmes contenant des cellules.
the hypothesis that unconjugated bilirubin and biliverdin are cytoprotective antioxidants has been examined for the first time in systems containing cells.
Last Update: 2015-05-14
Usage Frequency: 1
Quality:
les patients atteints de purpura thrombocytopénique auto-immun (pti) manifestant des signes et des symptômes d’hémolyse intravasculaire et de ses complications après l’administration de l’immunoglobuline anti-d devraient subir, dans le but de confirmer le diagnostic, des épreuves de laboratoire comprenant, sans toutefois s’y limiter, la formule sanguine (soit l’hémoglobine et la numération plaquettaire), l’haptoglobine, l’hémoglobine plasmatique, la colorimétrie de l’urine, l’analyse microscopique de l’urine, l’évaluation de la fonction rénale (soit l’azote uréique du sang et la créatinine sérique), la fonction hépatique (soit la ldh et la biliburine directe et indirecte) et des tests spécifiques au diagnostic de la coagulation intravasculaire disséminée (cid) des tests
patients being treated for itp should be instructed to immediately report symptoms of intravascular hemolysis (generalized weakness, lightheadedness, back pain, discolored urine, jaundice, decreased urine output, sudden weight gain, fluid retention/edema, and or shortness of breath) to their physicians. itp patients presenting with signs and/or symptoms of intravascular hemolysis and its complications after anti-d administration should have confirmatory laboratory testing that may include, but is not limited to cbc (i.e. hemoglobin, platelet counts), haptoglobin, plasma hemoglobin, urine dipstick, microscopic urinalysis, assessment of renal function (i.e. bun, serum creatinine), liver function (i.e. ldh, direct and indirect bilirubin) and dic specific tests such as d-dimer or fibrin degradation products (fdp) or fibrin split products (fsp).
Last Update: 2015-05-14
Usage Frequency: 1
Quality: